Showing results (41-50 of 130) with videos related to

Sort By:
Pageof 13
Clinical Transplantation|June 30, 2017
Retrospective evaluation of the efficacy and safety of belatacept with thymoglobulin induction and maintenance everolimus: A single-center clinical experienceDavid Wojciechowski, Sindhu Chandran, Joshua Y C Yang, et al.
Clinical Transplantation|January 5, 2022
Outcomes among CMV-mismatched and highly sensitized kidney transplants recipients who develop neutropeniaSandeep Brar, Reyoot Berry, Amit D Raval, et al.
Clinical Transplants|June 24, 2011
Kidney transplantation at UCSF: 8,300 transplants and onwardDavid Wojciechowski, Ryutaro Hirose, Peter Stock, et al.
Transplantation|July 17, 2003
CD69 expression on peripheral CD8 T cells correlates with acute rejection in renal transplant recipientsAndrew M Posselt, Flavio Vincenti, Melanie Bedolli, et al.
Biorxiv : the Preprint Server for Biology|September 16, 2020
Single-cell RNA sequencing of Tocilizumab-treated peripheral blood mononuclear cells as an in vitro model of inflammationArya Zarinsefat, George Hartoularos, Sindhu Chandran, et al.
Kidney International Reports|February 22, 2021
Phase 3 trial Design of the Hepatocyte Growth Factor Mimetic ANG-3777 in Renal Transplant Recipients With Delayed Graft FunctionFlavio Vincenti, Jim Kim, Deborah Gouveia, et al.
Nature Communications|April 25, 2019
Characterizing pre-transplant and post-transplant kidney rejection risk by B cell immune repertoire sequencingSilvia Pineda, Tara K Sigdel, Juliane M Liberto, et al.
Transplantation|May 9, 2009
The challenge of achieving target drug concentrations in clinical trials: experience from the Symphony studyHenrik Ekberg, Richard D Mamelok, Thomas C Pearson, et al.
Transplantation Direct|July 27, 2018
Nuclear Factor of Activated T Cell-regulated Cytokine Gene Expression for Adjustment of Tacrolimus in Kidney Transplant Recipients: A Randomized Controlled Pilot TrialAllison B Webber, Vasishta Tatapudi, Thin T Maw, et al.
Transplantation|October 13, 2012
Ciprofloxacin prophylaxis in kidney transplant recipients reduces BK virus infection at 3 months but not at 1 yearDavid Wojciechowski, Ranjan Chanda, Sindhu Chandran, et al.
Pageof 13